Solventum Co. (NYSE:SOLV) Given Consensus Rating of “Hold” by Analysts

Shares of Solventum Co. (NYSE:SOLV) have earned an average rating of “Hold” from the eleven research firms that are currently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, nine have issued a hold recommendation and one has issued a buy recommendation on the company. The average 12 month price objective among brokers that have updated their coverage on the stock in the last year is $68.29.

SOLV has been the topic of a number of research analyst reports. Stifel Nicolaus initiated coverage on shares of Solventum in a research note on Tuesday, October 8th. They set a “buy” rating and a $82.00 price objective on the stock. Wolfe Research began coverage on Solventum in a research note on Thursday, September 26th. They issued a “peer perform” rating on the stock. Mizuho initiated coverage on Solventum in a research note on Wednesday, December 4th. They set a “neutral” rating and a $70.00 target price for the company. Piper Sandler boosted their price target on shares of Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a research report on Friday, November 8th. Finally, Morgan Stanley raised their price objective on shares of Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a research report on Monday, November 11th.

Solventum Stock Performance

Solventum stock opened at $66.83 on Monday. Solventum has a 52 week low of $47.16 and a 52 week high of $96.05. The company’s 50-day moving average price is $70.90 and its two-hundred day moving average price is $63.55. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Copeland Capital Management LLC acquired a new position in Solventum in the 3rd quarter worth approximately $26,000. Mather Group LLC. acquired a new stake in shares of Solventum in the third quarter worth $27,000. Hollencrest Capital Management acquired a new stake in shares of Solventum in the second quarter worth $25,000. True Wealth Design LLC grew its holdings in shares of Solventum by 23,550.0% during the third quarter. True Wealth Design LLC now owns 473 shares of the company’s stock valued at $33,000 after buying an additional 471 shares in the last quarter. Finally, Deseret Mutual Benefit Administrators acquired a new position in Solventum during the second quarter valued at $25,000.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.